Stay updated on Oral Etrasimod in Crohn's Disease Clinical Trial
Sign up to get notified when there's something new on the Oral Etrasimod in Crohn's Disease Clinical Trial page.

Latest updates to the Oral Etrasimod in Crohn's Disease Clinical Trial page
- ChecktodayChange DetectedThe study record now indicates that recruitment has ceased for participants. The document revision has been updated from v3.5.5 to v3.6.0.SummaryDifference0.3%

- Check8 days agoChange DetectedA new site revision is shown: Revision: v3.5.5 replaces the previous v3.5.4, indicating an updated build of the page’s interface.SummaryDifference0.0%

- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedVersion 69 (Revision: v3.5.4) was added, introducing several new sections to the record history such as Adverse Events, Outcome Measures (Results), Baseline Characteristics, Participant Flow, Study Design, Study Status, and Study Identification; the latest entry also shows Returned: 2026-05-12 and indicates that the Quality Control Review Has Not Concluded.SummaryDifference0.8%

- Check43 days agoChange DetectedThe history section gains an entry for Revision: v3.5.3, replacing the previous v3.5.2. This reflects a new recorded update to the page.SummaryDifference0.0%

- Check50 days agoChange DetectedThe record’s status was updated to indicate that results have been submitted. Previously, the study showed no results posted.SummaryDifference0.0%

- Check58 days agoChange DetectedFooter revision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

Stay in the know with updates to Oral Etrasimod in Crohn's Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Oral Etrasimod in Crohn's Disease Clinical Trial page.